Cardiovascular Effects of Angiotensin-(1-7) in Obesity Hypertension
EARLY_PHASE1
52
about 4.2 years
18–65
1 site in PA
Why this study is shown
What this study is about
Researchers are testing a treatment called angiotensin-(1-7) to see if it can improve cardiovascular health in people with obesity and high blood pressure. The trial will last for 1528 days, and the goal is to enroll 52 participants.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Angiotensin-(1-7)
- 2.Take Saline
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
angiotensin II
Secondary: Change in Diastolic Blood Pressure, Change in Heart Rate, Change in Systolic Blood Pressure
Endocrinology, Cardiology / Heart